We are live on
!
Find out more
QC
Quadrature Capital Portfolio holdings
AUM
$11.7B
1-Year Est. Return
87.29%
This Fund
S&P 500
This Quarter
Est. Return
+5.32%
1 Year Est. Return
+87.29%
3 Year Est. Return
+211.84%
5 Year Est. Return
+162.22%
10 Year Est. Return
+656.25%
AUM
$9.8B
AUM Growth
+$1.34B
(+16%)
Cap. Flow
+$1.32B
Cap. Flow
% of AUM
13.46%
Top 10 Holdings %
Top 10 Hldgs %
22.18%
Holding
1,749
New
756
Increased
260
Reduced
198
Closed
532
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$299M |
| 2 |
Strategy Inc
MSTR
|
+$174M |
| 3 |
ServiceNow
NOW
|
+$152M |
| 4 |
Advanced Micro Devices
AMD
|
+$149M |
| 5 |
TSMC
TSM
|
+$145M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$282M |
| 2 |
Royal Bank of Canada
RY
|
+$265M |
| 3 |
Robinhood
HOOD
|
+$258M |
| 4 |
Palantir
PLTR
|
+$194M |
| 5 |
Apple
AAPL
|
+$164M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.12% |
| 2 | Consumer Discretionary | 12.45% |
| 3 | Industrials | 11.48% |
| 4 | Financials | 10.67% |
| 5 | Healthcare | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
UROY
1176
Uranium Royalty Corp
UROY
$1.57B
| $50.5K | ﹤0.01% |
+14,275
| New | +$55.9K |
|
|
AHMA
1177
Ambitions Enterprise Management Co
AHMA
$51.7M
| $50K | ﹤0.01% |
+10,128
| New | +$64.7K |
|
1178
Acrivon Therapeutics
ACRV
$74.5M
| $50K | ﹤0.01% |
+20,730
| New | +$45.1K |
|
1179
SKYX Platforms
SKYX
$164M
| $49K | ﹤0.01% |
22,577
+7,575
| +50% | +$13.5K |
|
1180
Erasca
ERAS
$6.29B
| $49K | ﹤0.01% |
+13,162
| New | +$37K |
|
1181
VinFast Auto
VFS
$7.46B
| $48.1K | ﹤0.01% |
+14,412
| New | +$48.1K |
|
|
NIU
1182
Niu Technologies
NIU
$160M
| $47.5K | ﹤0.01% |
+15,660
| New | +$60.6K |
|
1183
Unisys
UIS
$211M
| $47.3K | ﹤0.01% |
17,142
-8,409
| -33% | -$26.3K |
|
|
BLNE
1184
Beeline Holdings
BLNE
$36.8M
| $47.3K | ﹤0.01% |
+27,471
| New | +$66.7K |
|
|
BORR
1185
Borr Drilling
BORR
$1.28B
| $47.2K | ﹤0.01% |
+11,715
| New | +$38.8K |
|
|
GLDG
1186
GoldMining Inc
GLDG
$221M
| $44.3K | ﹤0.01% |
+35,428
| New | +$49.4K |
|
1187
Estrella Immunopharma
ESLA
$31.1M
| $43.3K | ﹤0.01% |
+27,781
| New | +$52.6K |
|
1188
Nkarta
NKTX
$176M
| $40.9K | ﹤0.01% |
22,111
-15,178
| -41% | -$30.3K |
|
1189
Cognition Therapeutics
CGTX
$94M
| $39.8K | ﹤0.01% |
29,513
-233,574
| -89% | -$379K |
|
1190
Biote Corp
BTMD
$46.7M
| $38.4K | ﹤0.01% |
+14,769
| New | +$40.4K |
|
1191
Altimmune
ALT
$593M
| $36.5K | ﹤0.01% |
+10,101
| New | +$44K |
|
1192
Yatra Online
YTRA
$52.8M
| $35.8K | ﹤0.01% |
+20,105
| New | +$33.1K |
|
1193
Leslie's
LESL
$10.4M
| $34.2K | ﹤0.01% |
+20,750
| New | +$67.3K |
|
1194
EVgo
EVGO
$224M
| $34.2K | ﹤0.01% |
11,758
+924
| +9% | +$3.36K |
|
1195
Expensify
EXFY
$225M
| $33.4K | ﹤0.01% |
22,131
-1,949
| -8% | -$3.09K |
|
|
BHR
1196
Braemar Hotels & Resorts
BHR
$139M
| $29.6K | ﹤0.01% |
+10,317
| New | +$27.8K |
|
1197
Clover Health Investments
CLOV
$2.41B
| $28.6K | ﹤0.01% |
+12,154
| New | +$33.2K |
|
1198
OraSure Technologies
OSUR
$275M
| $27.8K | ﹤0.01% |
+11,475
| New | +$30.2K |
|
|
WHWK
1199
Whitehawk Therapeutics
WHWK
$259M
| $27.7K | ﹤0.01% |
+11,447
| New | +$26.3K |
|
1200
Akebia Therapeutics
AKBA
$234M
| $26.7K | ﹤0.01% |
16,561
+6,293
| +61% | +$13.2K |
|
Similar funds
BCI
VA
PI
UE
LC
DWM
ERSOT
Quadrature Capital's Q4 2025 Portfolio in Review
As of Q4 2025, Quadrature Capital held 1,749 positions worth $9.8B, up 16% from $8.45B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Quadrature Capital deployed $1.32B of net new capital in Q4 2025, opening 756 new positions and adding to 260 existing holdings. Its largest new stake was UnitedHealth: 882,161 shares worth $291M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 27% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was Royal Bank of Canada, an estimated $265M trimmed.
- Quadrature Capital's largest Q4 2025 buy was UnitedHealth: 882,161 shares worth $291M.
- Quadrature Capital added most to Advanced Micro Devices in Q4 2025, an estimated $149M increase.
- Quadrature Capital's biggest Q4 2025 reduction was Royal Bank of Canada, cutting an estimated $265M.
- Quadrature Capital fully exited NVIDIA in Q4 2025, selling an estimated $282M.
- Quadrature Capital's ten largest holdings make up 22% of its $9.8B portfolio in Q4 2025.
- Quadrature Capital opened 756 new positions and closed 532 in Q4 2025.
- Quadrature Capital's portfolio value rose 16% quarter-over-quarter to $9.8B.
Based on Quadrature Capital's 13F filing for Q4 2025, filed 17 Feb 2026.